Could a common numbing drug replace opioids after cancer surgery?

NCT ID NCT02894710

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether giving the numbing drug lidocaine through a vein during and after ear, nose, and throat cancer surgery could lower the need for strong opioid painkillers and reduce long-term pain. 143 adults having major head and neck cancer surgery were randomly assigned to receive either lidocaine or a placebo. Researchers measured how much morphine patients needed in the first two days after surgery and checked for chronic pain 3 to 6 months later.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck cancer Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Léon Bérard

    Lyon, 69008, France

  • Hospices Civils de Lyon / Hôpital de la Croix Rousse

    Lyon, 69004, France